Gangnam Anti-Aging: Lines vs. Sagging, By Depth

Comparing Gangnam anti-aging treatments starts with one question: which tissue layer is the concern sitting in, not which device has the biggest name. Expression lines fold along a muscle's line of pull, while sagging comes from laxity in the dermis and the SMAS layer sitting beneath it, and each needs a different depth of correction. Treating both as one problem is the most common reason a patient leaves a consultation with a plan that doesn't match what they came in for.

Hello, I'm Dr. Kim Yeonjin, director of UH CELL Clinic's Gangnam branch. I want to walk through how I separate these two concerns in consultation, because the distinction changes everything that follows: which treatment gets recommended, how many sessions it takes, and what a reasonable outcome actually looks like.

Dynamic Lines, Static Lines: The First Split

A description registered with the U.S. National Institutes of Health's ClinicalTrials.gov (study NCT01586819) separates facial wrinkles into two categories: dynamic and static. Dynamic wrinkles form from repeated muscle contraction and soften when the muscle relaxes. Static wrinkles are what's left once the same fold has repeated long enough that it no longer fully disappears at rest, and they layer in with aging, gravity, and the gradual loss of subcutaneous fat.

That last part matters for planning. A line that is still purely dynamic responds well to reducing the muscle contraction that causes it. A line that has become static is being held partly by muscle activity and partly by structural change in the surrounding tissue, so muscle-only correction addresses one part of the problem and leaves the rest.

How a Neuromodulator Works, and Where That Mechanism Stops

Botulinum toxin acts at the neuromuscular junction. A literature review on botulinum toxin's clinical mechanism, published in CosmoDerma, describes the toxin binding to presynaptic cholinergic nerve terminals and blocking the release of acetylcholine, which reduces the signal telling the muscle to contract. A pharmacology review in the Indian Journal of Dermatology states that the resulting muscle weakness usually lasts about three months, after which the nerve terminal regenerates and contraction gradually returns toward baseline.

The mechanism is specific to muscle activity. It reduces the fold caused by repeated contraction, but it has no direct effect on tissue that has already loosened in the dermis or dropped in the SMAS layer. That is a separate structural problem, and it needs a treatment aimed at that structure, not at the muscle above it.

Sagging Is Compared by Depth, Not by Device Name

Skin laxity is where "which device" starts to matter less than "how deep, and does the practitioner know where the energy is going." A pan-Asian expert consensus published in the Journal of Clinical and Aesthetic Dermatology describes microfocused ultrasound with visualization, commonly known by the device name Ultherapy, delivering low-energy ultrasound at three fixed depths of 1.5mm, 3.0mm, and 4.5mm to heat tissue from the superficial dermis down to the SMAS layer, guided by real-time ultrasound imaging so the practitioner can see the target layer before firing.

A 2025 narrative review in the Journal of Cosmetic Dermatology adds the thermal detail: each of those three depths reaches a treatment temperature in the range of 60 to 70 degrees Celsius, which the review describes as the range associated with a neocollagenesis response, meaning it stimulates the tissue to build new collagen rather than simply heating it. In the United States, this technology's FDA clearance covers non-invasive lifting of the brow, neck, and submental (under-chin) area, plus improvement of décolletage lines. It is not cleared as a general face-lift substitute, and results build gradually as new collagen forms rather than appearing immediately after the session.

That framing changes what's worth asking in a consultation. The useful question isn't whether a clinic owns a particular machine. It's whether the sagging has been assessed at the depth it's actually occurring, and whether the energy delivered during treatment is confirmed at that depth in real time rather than estimated.

What I Check Before Recommending a Plan

I don't start from a device or a package. I start by asking the patient to make an expression and then relax, so I can see which lines disappear at rest and which don't. That single check tells me how much of what they're describing is dynamic, how much is static, and whether sagging is contributing to the static component.

From there, treatment planning separates into layers:

• Contraction-driven lines that soften at rest are addressed by reducing the muscle activity causing them.
• Lines that persist at rest, alongside visible laxity along the jawline, cheek, or under the chin, are assessed for which depth (1.5mm, 3.0mm, or 4.5mm) the laxity sits at before any energy is delivered.
• Volume loss from reduced subcutaneous fat is a separate factor from either of the above and is evaluated on its own before deciding whether it needs to be addressed at all.

I completed my graduate training at Seoul National University and my clinical training at Seoul National University Hospital. I serve as an Allergan faculty member and as a Key Doctor for Potenza and Ulthera, and I lecture with the Korean Society of Clinical Cosmetic Medicine. Our Gangnam branch is located on the second and third floors of the UH FLAT SIGNATURE Gangnam hotel, with Japanese, Chinese, and English-speaking staff on site for consultations. Guests staying at UHC group hotels may choose one complimentary recovery option, either a 30-minute oxygen chamber session or a vitamin IV drip; using both in the same visit adds a charge of 55,000 KRW for the second service.

FAQ

What if I have both expression lines and sagging at the same time?

These target different layers, so I evaluate each separately before deciding on sequencing and spacing between treatments. In consultation, I check the same area with the muscle active and then relaxed to see how much of the visible line is contraction versus structural laxity underneath it.

Does lifting only work well at the deepest setting, 4.5mm?

No. Depth is matched to where the target tissue sits, confirmed by imaging during the pre-treatment assessment. The pan-Asian consensus describes all three depths, 1.5mm, 3.0mm, and 4.5mm, as tools suited to different tissue layers, and the depth used in an individual treatment depends on what that assessment finds.

How long does a neuromodulator's effect actually last?

A pharmacology review in the Indian Journal of Dermatology states that the muscle weakness from botulinum toxin usually lasts about three months, after which the nerve terminal regenerates and contraction gradually returns. Individual response varies, so I recommend a follow-up check rather than assuming a fixed timeline for every patient.

Is sagging always treated with ultrasound at the deepest layer?

Not necessarily. Sagging is assessed layer by layer, and volume loss from reduced subcutaneous fat is a separate issue from dermal or SMAS laxity. Confirming which of these is actually present, and at what depth, comes before choosing any treatment.